Related Experiment Videos
Serotonin is a directly-acting hyperalgesic agent in the rat
1Department of Medicine, University of California, San Francisco 94143-0452A.
Neuroscience
|January 1, 1992
Summary
Serotonin causes hyperalgesia through direct action on primary afferent neurons, specifically via the 5-HT1A receptor. This finding was confirmed using selective agonists and antagonists in a rat paw withdrawal model.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Serotonin (5-hydroxytryptamine; 5-HT) is implicated in pain modulation.
- The precise mechanisms of serotonin-induced hyperalgesia are not fully understood.
- Previous studies suggest indirect pathways may contribute to serotonin's effects.
Purpose of the Study:
- To investigate the direct role of serotonin in inducing hyperalgesia.
- To identify the specific serotonin receptor subtypes involved in this effect.
- To elucidate the neuronal pathways mediating serotonin hyperalgesia.
Main Methods:
- Utilized the mechanical paw withdrawal nociceptive threshold test in rats.
- Administered intradermal injections of serotonin and selective receptor agonists/antagonists.
- Assessed hyperalgesia onset, duration, and attenuation by receptor blockers.
Main Results:
- Intradermal serotonin induced dose-dependent hyperalgesia with rapid onset (<1 min).
- Hyperalgesia was not affected by sympathectomy, leukocyte depletion, or cyclooxygenase inhibition.
- Selective 5-HT1A receptor agonists produced hyperalgesia, while agonists for 5-HT1B, 5-HT2, and 5-HT3 receptors did not.
- 5-HT1A antagonists, but not antagonists for other subtypes, attenuated serotonin-induced hyperalgesia.
Conclusions:
- Serotonin directly induces hyperalgesia via primary afferent neurons.
- The 5-HT1A receptor subtype is critically involved in mediating serotonin hyperalgesia.
- Findings suggest a direct neuronal mechanism for serotonin's role in pain sensitization.